Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-23

FDA Approved: SILDENAFIL — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' original application for sildenafil, a generic version of the erectile dysfunction treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sildenafil (generic) (Sildenafil)

Snippet

ORIG AP for SILDENAFIL (SILDENAFIL)